Institut Gustave Roussy
Also known as: Cancer Institute Gustave Roussy | Department of Medical Oncology Institut Gustave Roussy,Villejuif,France | GINECO - Gustave Roussy | Gustave Roussy | Gustave ROUSSY | GUSTAVE ROUSSY | Gustave Roussy Cancer Campus | Gustave Roussy, Cancer Campus, Grand Paris | Gustave Roussy, Cancer Campus Grand Paris - Paris | Gustave Roussy, Cancer Campus Grand Paris-Paris | Gustave Roussy Cancer Campus - Villejuif | Gustave Roussy Cancer Institute | Gustave Roussy, Ditep | Gustave Roussy Institut | Gustave Roussy Institute | Gustave Roussy, Paris, France | Gustave roussy, Villejuif | Gustave Roussy Villejuif | Gustave Roussy, Villejuif | Gustave Roussy (Villejuif - France) | Gustave Roussy, Villejuif, France | Institut de Cancerology Gustave Roussy, France | Institute Gustave Roussy, France | Institut Gustave Roussy, 94805 Villejuif, France | Institut Gustave Roussy Cancer Campus Grand Paris | Institut Gustave Roussy Cancer, Villejuif, France - LYSA | Institut Gustave Roussy, France | Institut Gustave Roussy (IGR) | Institut Gustave-Roussy (IGR) | INSTITUT GUSTAVE ROUSSY, Paris, France | Institut Gustave Roussy - Villejuif | Institut Gustave-Roussy, Villejuif Cedex, France | Institut Gustave Roussy, Villejuif, France | Institut Gustave Roussy, Villejuif, FRANCE | Institut Gustave Roussy VILLEJUIF France | Institut Gustave Roussy, Villejuif, Paris, France | Institut Gustav Roussy (IGR) | Medical Oncology Department Gustave Roussy, Villejuif (France)
Highest phase reached
Phase 4
First clinical trial
Mar 1, 1993Last known activity
Feb 28, 2026
Timeline
1920s
- Jan 1, 1926
Institut Gustave Roussy— Founded
Drugs by trial phase (218 distinct, 265 trials)
Phase 4 (3 own, 0 via acquisition)
Phase 3 (94 own, 0 via acquisition)
Phase 2 (99 own, 0 via acquisition)
Phase 1 (18 own, 0 via acquisition)
Other trials (4 own, 0 via acquisition)
Indications
Studied for
- Adenocarcinoma
- Aggression
- Anus Neoplasms
- Biliary Tract Neoplasms
- Brain Neoplasms
- Breast Neoplasms
- Burkitt Lymphoma
- Cancer Pain
- Carcinoma
- Carcinoma, Adenoid Cystic
- Carcinoma, Hepatocellular
- Carcinoma, Islet Cell
- Carcinoma, Neuroendocrine
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Ovarian Epithelial
- Carcinoma, Renal Cell
- Carcinoma, Squamous Cell
- Carcinoma, Transitional Cell
- Carotid Body Tumor
- Central Nervous System Neoplasms
- Colorectal Neoplasms
- Disease
- Disease Progression
- Endocrine Gland Neoplasms
- Endometrial Neoplasms
- Esophageal Neoplasms
- Fibrosis
- Gastrointestinal Stromal Tumors
- Glioblastoma
- Glioma
- Head and Neck Neoplasms
- Hematologic Neoplasms
- Hepatoblastoma
- Hodgkin Disease
- Hypersensitivity
- Intestinal Neoplasms
- Kidney Neoplasms
- Laryngeal Neoplasms
- Leiomyosarcoma
- Leukemia
- Leukemia, B-Cell
- Leukemia, Lymphocytic, Chronic, B-Cell
- Leukemia, Myelomonocytic, Acute
- Leukemia, Myelomonocytic, Chronic
- Leukemia, Myelomonocytic, Juvenile
- Liver Neoplasms
- Lung Neoplasms
- Lymphoma
- Lymphoma, B-Cell
- Lymphoma, Follicular
- Lymphoma, Large B-Cell, Diffuse
- Lymphoma, Large-Cell, Anaplastic
- Lymphoma, Non-Hodgkin
- Medulloblastoma
- Melanoma
- Microsatellite Instability
- Mouth Neoplasms
- Nasopharyngeal Carcinoma
- Neoplasm Metastasis
- Neoplasms
- Neoplasms, Connective and Soft Tissue
- Neoplasms, Germ Cell and Embryonal
- Neoplasms, Glandular and Epithelial
- Neoplasms, Second Primary
- Nervous System Neoplasms
- Neuroblastoma
- Neuroectodermal Tumors
- Neuroectodermal Tumors, Primitive
- Oropharyngeal Neoplasms
- Osteosarcoma
- Ovarian Neoplasms
- Pancreatic Neoplasms
- Paraganglioma
- Penile Neoplasms
- Peritoneal Neoplasms
- Pheochromocytoma
- Polycythemia
- Polycythemia Vera
- Postoperative Pain
- Precancerous Conditions
- Primary Myelofibrosis
- Prostatic Neoplasms
- Recurrence
- Rhabdomyosarcoma
- Sarcoma
- Sarcoma, Ewing
- Seminoma
- Skin Neoplasms
- Small Cell Lung Carcinoma
- Squamous Cell Carcinoma of Head and Neck
- Stomach Neoplasms
- Stress, Psychological
- Teratoma
- Testicular Neoplasms
- Thrombocythemia, Essential
- Thrombocytosis
- Thymoma
- Thymus Neoplasms
- Thyroid Carcinoma, Anaplastic
- Thyroid Diseases
Recent trials (50)
- NCT07303387Lead sponsorPhase 2Feb 28, 2026
- NCT07192068OfficialPhase 2Oct 30, 2025
- NCT07082452Lead sponsorPhase 3Sep 30, 2025
- NCT07159451Lead sponsorPhase 2Sep 23, 2025
- NCT07016230Lead sponsorPhase 2Jul 2, 2025
- NCT06878664OfficialPhase 3Jun 12, 2025
- NCT06934057OfficialPhase 4May 16, 2025
- NCT06934057Lead sponsorPhase 4May 16, 2025
- NCT06680596OfficialPhase 2Mar 30, 2025
- NCT06787118Lead sponsorPhase 3Feb 28, 2025
- NCT06625970OfficialPhase 3Jan 31, 2025
- NCT06713798Lead sponsorPhase 2Jan 31, 2025
- NCT06606730OfficialPhase 3Jan 1, 2025
- NCT06475352OfficialPhase 2Dec 31, 2024
- NCT06642844CollaboratorPhase 3Oct 30, 2024
Details
- Founded
- Villejuif, FR Jan 1, 1926
- Last known activity
- Feb 28, 2026